查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
欧洲尿道填充系统市场 - 产业分析、规模、份额、成长、趋势、预测 (2031) - 按产品、按最终用户、按国家：（欧洲）
市场调查报告书
商品编码
1398756

欧洲尿道填充系统市场 - 产业分析、规模、份额、成长、趋势、预测 (2031) - 按产品、按最终用户、按国家：（欧洲）

Europe Urethral Bulking Systems Market - Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (Europe)
出版日期: | 出版商: Fairfield Market Research | 英文 181 Pages | 商品交期: 2-5个工作天内

价格
简介目录

欧洲尿道填充系统市场规模预计将显着成长，营收预计将从 2024 年的 2,500 万美元增至 2031 年底的约 4,200 万美元。

尿道膨胀系统用于治疗压力性尿失禁，这种尿失禁会导致女性感到羞耻和不适，尤其是在社交场合。 包括世界卫生组织 (WHO) 和医疗保健组织在内的各种组织正在努力提高对女性压力性尿失禁的认识，并提高对现有治疗方案的接受度。

压力性尿失禁在孕妇中普遍存在，影响她们的生活品质。 许多国家的政府正在积极提高人们对女性压力性尿失禁的认识，导致尿道膨胀系统的销售增加。 怀孕率上升是压力性尿失禁的主要风险因素，政府的资助预计将推动市场成长。

老年女性数量的快速增加是导致压力性尿失禁盛行率上升的重要因素。 人口老化与压力性尿失禁病例的增加密切相关。

压力性尿失禁患者有多种治疗选择，包括手术、药物、导尿、神经刺激和使用设备。 失禁护理产品等替代品的出现可能会限制尿道膨胀系统市场。

已有通报与尿道膨胀相关的严重副作用，例如尿道下脓疡、尿道脱垂和颗粒迁移。 这些併发症对尿道膨胀系统的广泛使用提出了挑战。

本报告调查了欧洲尿道膨胀系统市场，并提供了市场概述，包括按产品、最终用户、国家/地区划分的趋势以及进入市场的公司的竞争趋势。

目录

第 1 章执行摘要

第二章市场概述

  • 市场定义与细分
  • 市场动态
  • 价值链分析
  • 波特五力分析
  • 新冠肺炎 (COVID-19) 影响分析
  • 乌克兰和俄罗斯之间衝突的影响
  • 经济概况
  • 杵分析

第 3 章欧洲尿道填充系统市场前景，2018-2031

  • 2018-2031 年欧洲尿道填充系统市场前景（按产品、价值（百万美元））
  • 2018-2031 年欧洲尿道膨胀系统市场前景（按最终用户划分）价值（百万美元）
  • 2018-2031 年欧洲尿道膨胀系统市场前景（按国家/地区划分）、价值（百万美元）

第四章竞争态势

  • 产品和最终用户热图
  • 製造商和最终用户的热图
  • 2023 年公司市占率分析
  • 竞争力仪表板
  • 公司简介
    • Boston Scientific Corporation
    • Coloplast Corporation
    • Axonics Modulation Technologies, Inc. (Contura, Inc.)
    • Palette Life Sciences, Inc.
    • Laborie, Inc.

第五章附录

简介目录

The Europe Urethral Bulking Systems Market is set to experience substantial growth, with revenue expected to increase from US$ 25 million in 2024 to approximately US$ 42 million by the end of 2031, according to the latest market analysis by Fairfield Market Research.

Understanding Urethral Bulking Systems

Urethral bulking systems are used to treat stress urinary incontinence, a condition that affects women and can cause embarrassment and discomfort, particularly in social settings. Various organizations, including the World Health Organization and healthcare groups, have worked to raise awareness about female stress urinary incontinence, increasing the acceptance of available treatment options.

Key Market Drivers

High Pregnancy Rate and Government Support: Stress urinary incontinence is prevalent among pregnant women, impacting their quality of life. Governments in many countries are actively promoting awareness about female stress urinary incontinence, leading to increased sales of urethral bulking systems. The rising pregnancy rate, a key risk factor for stress urinary incontinence, and government funding are expected to drive market growth.

Growing Geriatric Population: The rapid increase in the number of elderly women is a significant factor contributing to the rising prevalence of stress urinary incontinence. Aging is closely linked to an increase in stress urinary incontinence cases.

Awareness Initiatives: Several companies are actively engaged in raising awareness of incontinence and providing educational programs to healthcare workers and the general public. These initiatives aim to enhance understanding of urological problems, their causes, risk factors, and treatment options.

Market Challenges

Presence of Alternatives: Patients with stress urinary incontinence have various treatment options, including surgery, medication, catheterization, nerve stimulation, or device use. The availability of alternatives like incontinence care products may restrain the urethral bulking systems market.

Complications Associated with Urethral Bulking Systems: There have been reported cases of severe side effects associated with urethral bulking, including suburethral abscess, urethral prolapse, and particle migration. These complications pose challenges to the adoption of urethral bulking systems.

Market Insights for Germany

The German market is experiencing growth due to the increasing incidence of urethral incontinence in females. Key contributing factors include menopause, hysterectomy, pregnancy, childbirth, and changing lifestyles.

Outlook for the UK Market

In the UK, 24% of the female population is estimated to be affected by stress incontinence, according to the National Institute for Health and Care Excellence (NICE). This makes the UK a potentially lucrative market for manufacturers.

Competitive Landscape

Mergers and acquisitions have become primary growth strategies in the European urethral bulking systems market. Leading manufacturers are expanding their product lines through acquisitions and targeting both established and emerging markets. Key players are also focusing on growth, new product launches, and expanding their sales channels, including online sales.

Market Segmentation

Product:

  • Pyrolytic carbon-coated graphite beads
  • Calcium Hydroxylapatite Based
  • Polydimethylsiloxane macroparticle
  • Polyacrylamide hydrogel
  • Hyaluronic Acid Based

End User:

  • Hospitals
  • Ambulatory Surgical centers
  • Specialty Clinic

Country:

  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Benelux
  • Nordic Countries
  • Rest of Europe

Table of Contents

1. Executive Summary

  • 1.1. Europe Urethral Bulking Systems Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Europe Urethral Bulking Systems Market Outlook, 2018 - 2031

  • 3.1. Europe Urethral Bulking Systems Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Pyrolytic carbon-coated graphite beads
      • 3.1.1.2. Calcium Hydroxylapatite based
      • 3.1.1.3. Polydimethylsiloxane macroparticle
      • 3.1.1.4. Polyacrylamide hydrogel
      • 3.1.1.5. Hyaluronic Acid Based
  • 3.2. Europe Urethral Bulking Systems Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Hospitals
      • 3.2.1.2. Ambulatory Surgical centers
      • 3.2.1.3. Specialty Clinic
  • 3.3. Europe Urethral Bulking Systems Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. Germany Urethral Bulking Systems Market by Product, Value (US$ Mn), 2018 - 2031
      • 3.3.1.2. Germany Urethral Bulking Systems Market by End User, Value (US$ Mn), 2018 - 2031
      • 3.3.1.3. U.K. Urethral Bulking Systems Market by Product, Value (US$ Mn), 2018 - 2031
      • 3.3.1.4. U.K. Urethral Bulking Systems Market by End User, Value (US$ Mn), 2018 - 2031
      • 3.3.1.5. France Urethral Bulking Systems Market by Product, Value (US$ Mn), 2018 - 2031
      • 3.3.1.6. France Urethral Bulking Systems Market by End User, Value (US$ Mn), 2018 - 2031
      • 3.3.1.7. Italy Urethral Bulking Systems Market by Product, Value (US$ Mn), 2018 - 2031
      • 3.3.1.8. Italy Urethral Bulking Systems Market by End User, Value (US$ Mn), 2018 - 2031
      • 3.3.1.9. Turkey Urethral Bulking Systems Market by Product, Value (US$ Mn), 2018 - 2031
      • 3.3.1.10. Turkey Urethral Bulking Systems Market by End User, Value (US$ Mn), 2018 - 2031
      • 3.3.1.11. Russia Urethral Bulking Systems Market by Product, Value (US$ Mn), 2018 - 2031
      • 3.3.1.12. Russia Urethral Bulking Systems Market by End User, Value (US$ Mn), 2018 - 2031
      • 3.3.1.13. Rest of Europe Urethral Bulking Systems Market by Product, Value (US$ Mn), 2018 - 2031
      • 3.3.1.14. Rest of Europe Urethral Bulking Systems Market by End User, Value (US$ Mn), 2018 - 2031
    • 3.3.2. BPS Analysis/Market Attractiveness Analysis

4. Competitive Landscape

  • 4.1. Product vs End User Heatmap
  • 4.2. Manufacturer vs End User Heatmap
  • 4.3. Company Market Share Analysis, 2023
  • 4.4. Competitive Dashboard
  • 4.5. Company Profiles
    • 4.5.1. Boston Scientific Corporation
      • 4.5.1.1. Company Overview
      • 4.5.1.2. Product Portfolio
      • 4.5.1.3. Financial Overview
      • 4.5.1.4. Business Strategies and Development
    • 4.5.2. Coloplast Corporation
      • 4.5.2.1. Company Overview
      • 4.5.2.2. Product Portfolio
      • 4.5.2.3. Financial Overview
      • 4.5.2.4. Business Strategies and Development
    • 4.5.3. Axonics Modulation Technologies, Inc. (Contura, Inc.)
      • 4.5.3.1. Company Overview
      • 4.5.3.2. Product Portfolio
      • 4.5.3.3. Financial Overview
      • 4.5.3.4. Business Strategies and Development
    • 4.5.4. Palette Life Sciences, Inc.
      • 4.5.4.1. Company Overview
      • 4.5.4.2. Product Portfolio
      • 4.5.4.3. Financial Overview
      • 4.5.4.4. Business Strategies and Development
    • 4.5.5. Laborie, Inc.
      • 4.5.5.1. Company Overview
      • 4.5.5.2. Product Portfolio
      • 4.5.5.3. Financial Overview
      • 4.5.5.4. Business Strategies and Development

5. Appendix

  • 5.1. Research Methodology
  • 5.2. Report Assumptions
  • 5.3. Acronyms and Abbreviations